These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3699402)

  • 1. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.
    Pockros PJ; Reynolds TB
    Gastroenterology; 1986 Jun; 90(6):1827-33. PubMed ID: 3699402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea.
    Decaux G; Mols P; Cauchie P; Flamion B; Delwiche F
    Nephron; 1986; 44(4):337-43. PubMed ID: 3796773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
    Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
    Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascites kinetics in cirrhosis: effects of rapid volume expansion and diuretic administration.
    Rector WG
    J Lab Clin Med; 1988 Feb; 111(2):166-72. PubMed ID: 3339270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a single, intravenous dose of bumetanide versus furosemide in patients with ascites and edema due to alcoholic liver disease.
    Koff RS
    J Clin Pharmacol; 1981; 21(11):706-11. PubMed ID: 7040497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
    Fuller RK; Khambatta PB; Gobezie GC
    JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilization of ascites in cirrhotic dogs following furosemide or mannitol diuresis.
    Levy M; Richard C
    Am J Physiol; 1978 Jul; 235(1):F12-21. PubMed ID: 677315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of the use of "Spirolang" 50].
    Gentili G; Liberti R
    Minerva Med; 1971 Feb; 62(17):816-27. PubMed ID: 5551769
    [No Abstract]   [Full Text] [Related]  

  • 9. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
    Heinrich F; Loew D; Dýcka J
    Curr Med Res Opin; 1976-1977; 4(10):706-15. PubMed ID: 800972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics.
    Pockros PJ; Esrason KT; Nguyen C; Duque J; Woods S
    Gastroenterology; 1992 Oct; 103(4):1302-6. PubMed ID: 1397889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites.
    Campra JL; Reynolds TB
    Am J Dig Dis; 1978 Nov; 23(11):1025-30. PubMed ID: 31086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer diuretics in the treatment of cardiac or hepatic disease in elderly patients.
    Steigmann F; Oz R; Dubin A
    J Am Geriatr Soc; 1966 Dec; 14(12):1232-8. PubMed ID: 5954532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyponatremic syndrome after salt-free diet, enforced diuresis and/or paracentesis for ascites in chronic liver insufficiency; hyponatremia, hypochloremia, hyperkalemia and azotemia].
    MARTINI GA; RAUSCH-STROOMANN JG
    Klin Wochenschr; 1959 Apr; 37(7):385-94. PubMed ID: 13642774
    [No Abstract]   [Full Text] [Related]  

  • 14. Use, misuse and abuse of diuretics.
    Bartoli E; Rossi L; Sola D; Castello L; Sainaghi PP; Smirne C
    Eur J Intern Med; 2017 Apr; 39():9-17. PubMed ID: 28233622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
    Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
    J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of diuresis in the alcoholic patient with ascites: a controlled trial.
    Gregory PB; Broekelschen PH; Hill MD; Lipton AB; Knauer CM; Egger M; Miller R
    Gastroenterology; 1977 Sep; 73(3):534-8. PubMed ID: 892352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of loop diuretics: a comparative study.
    Ansuini R; Pulido M; Pupita G; Gaggi S; Pupita F
    Int J Clin Pharmacol Res; 1985; 5(2):113-21. PubMed ID: 4018941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term course of corticosteroids in the treatment of resistant ascites complicating schistosomal liver disease.
    el-Zayadi A; Mohran Z; Hasseeb N; Nagy N; Dabbous H
    Am J Gastroenterol; 1991 Jan; 86(1):53-6. PubMed ID: 1986555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of six treatments of ascites in patients with liver cirrhosis. A clinical trial.
    Descos L; Gauthier A; Levy VG; Michel H; Quinton A; Rueff B; Fermanian J; Fombonne E; Durbec JP
    Hepatogastroenterology; 1983 Feb; 30(1):15-20. PubMed ID: 6339343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.